Nicolet Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Nicolet Advisory Services's VRTX Position: Q4 2025 in Review
Nicolet Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q4 2025, selling an estimated $53.4K and leaving 711 shares worth $327K. The position accounts for 0.02% of the portfolio, ranked #314.
Nicolet Advisory Services first reported a position in VRTX in Q3 2023 and has held it in 10 quarters since. The position peaked at $501K in Q2 2025. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.
- Nicolet Advisory Services held 711 shares of Vertex Pharmaceuticals worth $327K as of Q4 2025.
- Nicolet Advisory Services sold 124 Vertex Pharmaceuticals shares in Q4 2025, an estimated $53.4K.
- Vertex Pharmaceuticals made up 0.02% of Nicolet Advisory Services's portfolio in Q4 2025, its #314 holding.
- Nicolet Advisory Services first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
- Nicolet Advisory Services's Vertex Pharmaceuticals position peaked at $501K in Q2 2025.
- 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.
Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.